Tata Mutual Fund is quite optimistic on the general consumer discretionary space on account of our expectations of rising per capita GDP over the next 5 years.
“In the pharmaceuticals segment, every company seems to be a different sector in itself. We are very optimistic in the pharmaceutical manufacturing or CDMO space where we see a multi-year scalable opportunity for the Indian companies. On the generic side, we are very choosy. We have exposure in limited names.”
In a pre-IPO placement, external investor Blue Chandra had sold 10.32 million shares or 8.4 per cent of its stake to renowned investor Madhusudan Kela s wife Madhuri Kela, along with Nuvama Crossover Opportunities Fund and TIMF Holdings, for a total consideration of Rs 130 crore.
Samhi Hotels has raised Rs 616.54 crore from anchor investors before its initial share sale. The company has allocated equity shares to 35 entities at an average price of Rs 126 apiece. Anchor investors include SBI Mutual Fund, Aditya Birla Sun Life MF, ICICI Prudential MF, and Tata MF. The IPO comprises fresh issuance of equity shares worth up to Rs 1,200 crore and an Offer For Sale of up to 1.35 crore shares. Samhi Hotels acquires/builds primary hotels and currently owns 4,800 keys across 31 operating hotels.